Helicobacter pylori gastritis and serum pepsinogen levels in a healthy population: development of a biomarker strategy for gastric atrophy in high-risk groups
1996

Helicobacter pylori and Pepsinogen Levels in Healthy Workers

Sample size: 544 publication Evidence: moderate

Author Information

Author(s): T Knight, J Wyatt, A Wilson, S Greaves, D Newell, K Hengels, M Corlett, P Webb, D Forman, J Elder

Primary Institution: Keele University

Hypothesis

Can serum pepsinogen levels and Helicobacter pylori serology identify individuals at risk of gastric atrophy and cancer?

Conclusion

The study suggests that combining serum pepsinogen levels with Helicobacter pylori serology can effectively identify individuals at increased risk of gastric carcinoma.

Supporting Evidence

  • 29 out of 54 endoscoped subjects were seropositive for Helicobacter pylori.
  • 88.9% sensitivity and 92.3% specificity were achieved using the biomarker combination.
  • 9 subjects had corpus atrophy, mostly with fasting hypochlorhydria and hypergastrinaemia.

Takeaway

This study looked at factory workers to see if certain blood tests could help find people at risk for stomach cancer. They found that specific blood markers could help identify those at risk.

Methodology

The study involved blood tests and endoscopy on a subsample of male factory workers to measure serum pepsinogen and Helicobacter pylori levels.

Potential Biases

Potential selection bias due to the specific occupational group studied.

Limitations

The study was conducted only among male workers, which may limit the applicability of the results to females.

Participant Demographics

Male factory workers aged 18-63 years.

Statistical Information

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication